Publication

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression

Related publications (34)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression

Graph Chatbot

Chat with Graph Search

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits

Endogenous Regulators of Gamma-Secretase and Amyloid-Beta Production, and Engineering of Alzheimer's Disease Therapeutic Tools

Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease

An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease

Attention-Related Potentials Allow for a Highly Accurate Discrimination of Mild Cognitive Impairment Subtypes

Age-related cognitive impairments in mice with a conditional ablation of the neural cell adhesion molecule

Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain

Explaining the length threshold of polyglutamine aggregation

The riddle of style changes in the visual arts after interference with the right brain

Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1)